Sign in

CIK 0001878313

  • Emerging growth company

MAIA Biotechnology, Inc.

Sign in to watch
Ticker
MAIA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 312-416-8592
Business address
444 WEST LAKE STREET, SUITE 1700, CHICAGO, IL, 60606
  1. 4 Open-market buy Director bought 1,500 shares at $3.98 ($5,970)
  2. 4 Open-market buy Director bought 3,582 shares at $4.03 ($14,435)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market buy Director bought 2,741 shares at an average $4.03 ($11,060)
  8. 4 Open-market buy Director bought 5,037 shares at an average $4.21 ($21,214)
  9. 4 Open-market buy Chief Executive Officer bought 1,581 shares at $4.21 ($6,656)
  10. 4 Open-market buy Director bought 2,215 shares at an average $4.23 ($9,375)
  11. 4 Open-market buy Director bought 1,352 shares at an average $4.25 ($5,741)
  12. 4 Open-market buy Chief Executive Officer bought 1,983 shares at $4.24 ($8,408)
  13. 4 Open-market buy Director bought 7,103 shares at an average $4.40 ($31,283)
  14. 4 Open-market buy Chief Executive Officer bought 2,443 shares at an average $4.47 ($10,918)
  15. 4 Open-market buy Director bought 221 shares at an average $4.47 ($988)
  16. 4 Open-market buy Chief Executive Officer bought 1,557 shares at an average $4.49 ($6,988)
  17. 4 Open-market buy Director bought 1,838 shares at an average $4.48 ($8,232)
  18. 4 Open-market buy Director bought 1,301 shares at an average $4.48 ($5,831)
  19. 4 Open-market buy Chief Executive Officer bought 73 shares at $4.25 ($310)
  20. 4 Open-market buy Director bought 137 shares at $4.25 ($582)

Page 10 of 13 · 250 filings